Primary CNS lymphoma (PCNSL), an uncommon form of extranodal non-Hodgkin's
lymphoma (NHL), has increased in incidence during the last three decades and occurs in …

Primary Central Nervous System Lymphoma (PCNSL) is a rare neoplasm that can involve
brain, eye, leptomeninges, and rarely spinal cord. PCNSL lesions most typically enhance …

Standardized guidelines for the baseline evaluation and response assessment of primary
CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly …

Purpose We previously reported a series of patients treated with high-dose methotrexate
(MTX)-based chemotherapy, with or without whole brain radiotherapy. The purpose of this …

Purpose Primary CNS lymphoma (PCNSL) is confined to the CNS and/or the eyes at
presentation and is usually initially treated with intravenous methotrexate-based …

Objective: To describe and correlate neurotoxicity indicators in long-term primary CNS
lymphoma (PCNSL) survivors who were treated with high-dose methotrexate–based …

OBJECTIVE: Ferumoxytol, an iron oxide nanoparticle that targets phagocytic cells, can be
used in magnetic resonance imaging of malignant brain tumors and can be administered as …

Introduction The standard treatment for primary central nervous system lymphoma (PCNSL)
involves induction methotrexate-based chemotherapy with or without consolidation whole …

Background: Treatment-related neurotoxicity has been recognized as a significant problem
in patients with primary central nervous system lymphoma (PCNSL) as effective treatment …

Object The authors assessed the safety and maximum tolerated dose of superselective
intraarterial cerebral infusion (SIACI) of bevacizumab after osmotic disruption of the blood …